Dysregulation of MLL1 is associated with acute myeloid and lymphoblastic leukemias, with MLL-rearranged (MLL-r) cancers retaining a wildtype copy of MLL1 whose activity has separately been ascertained as essential6,7 or nonessential8 for leukemogenesis. The gene discussed is KMT2A; the disease is cancer.